chr6-65296034-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001142800.2(EYS):c.1852G>A(p.Gly618Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000152 in 1,551,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001142800.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EYS | NM_001142800.2 | c.1852G>A | p.Gly618Ser | missense_variant | 12/43 | ENST00000503581.6 | NP_001136272.1 | |
EYS | NM_001292009.2 | c.1852G>A | p.Gly618Ser | missense_variant | 12/44 | NP_001278938.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EYS | ENST00000503581.6 | c.1852G>A | p.Gly618Ser | missense_variant | 12/43 | 5 | NM_001142800.2 | ENSP00000424243 | A2 | |
EYS | ENST00000370621.7 | c.1852G>A | p.Gly618Ser | missense_variant | 12/44 | 1 | ENSP00000359655 | P2 | ||
EYS | ENST00000370615.3 | n.290G>A | non_coding_transcript_exon_variant | 2/2 | 3 | |||||
EYS | ENST00000447127.1 | n.308G>A | non_coding_transcript_exon_variant | 3/3 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000408 AC: 62AN: 151952Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000115 AC: 18AN: 157080Hom.: 0 AF XY: 0.0000964 AC XY: 8AN XY: 83002
GnomAD4 exome AF: 0.000124 AC: 173AN: 1399030Hom.: 0 Cov.: 40 AF XY: 0.000123 AC XY: 85AN XY: 690022
GnomAD4 genome AF: 0.000408 AC: 62AN: 152070Hom.: 0 Cov.: 33 AF XY: 0.000336 AC XY: 25AN XY: 74354
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:3Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2023 | EYS: BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 08, 2020 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Identified in individuals with retinitis pigmentosa in published literature, however, this variant did not segregate with disease in one family and another study considered this variant to be likely benign (Audo et al., 2010; Gonzalez-del Pozo et al., 2011; Messchaert et al., 2018); This variant is associated with the following publications: (PMID: 22164218, 29159838, 20333770, 31456290) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 618 of the EYS protein (p.Gly618Ser). This variant is present in population databases (rs142450703, gnomAD 0.1%). This missense change has been observed in individuals with clinical features of EYS-related conditions (PMID: 20333770, 31456290, 35836572; Invitae). ClinVar contains an entry for this variant (Variation ID: 551873). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Retinitis pigmentosa 25 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | May 10, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 31, 2022 | - - |
Retinitis pigmentosa Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | Sharon lab, Hadassah-Hebrew University Medical Center | Jun 23, 2019 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 08, 2022 | Variant summary: EYS c.1852G>A (p.Gly618Ser) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00016 in 188434 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in EYS causing Retinitis Pigmentosa (0.00016 vs 0.0034), allowing no conclusion about variant significance. c.1852G>A has been reported in the literature in individuals affected with Retinitis Pigmentosa (Gonzalez-del Pozo_2011, Sharon_2020), including one confirmed compound heterozygote (Audo_2010). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four ClinVar submitters have assessed the variant since 2014: three classified the variant as of uncertain significance and one as likely pathogenic. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at